Zimmer Biomet Holdings ZBH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Hips | $2.09B+4.7% | $2B+1.6% | $1.97B+3.8% | $1.89B+2.1% | |
| Knees | $3.32B+4.7% | $3.17B+4.4% | $3.04B+9.4% | $2.78B+4.9% | |
| SET | $2.15B+15.3% | $1.87B+6.4% | $1.75B+3.3% | $1.7B-1.8% | |
| Technology And Data Bone Cement And Surgical | $665.5M+3.9% | $640.3M+0.7% | $636M+11.6% | $570M— | |
| Revenue by Geography | |||||
| Americas | $5.15B+7.3% | $4.79B+3.7% | $4.62B+7.7% | $4.3B+4.7% | |
| Asia Pacific | $1.26B+5.4% | $1.19B+1.3% | $1.18B-0.9% | $1.19B-4.8% | |
| EMEA | $1.83B+8.1% | $1.69B+6.2% | $1.59B+9.3% | $1.46B-1.4% | |
| US | $4.76B+7.3% | $4.44B+3.5% | $4.29B+6.9% | $4.01B+4.1% | |
| Selling General And Administrative Expense by Geography | |||||
| Americas | $1.41B+14.4% | $1.23B+5.7% | $1.17B+6.4% | $1.09B— | |
| Asia Pacific | $359.9M+5.2% | $342M-5.7% | $362.5M-0.2% | $363.3M— | |
| EMEA | $537.1M+7.7% | $498.9M0.0% | $498.8M+3.2% | $483.2M— | |
| Operating Income by Geography | |||||
| Americas | $2.53B-1.8% | $2.58B+3.6% | $2.49B+9.1% | $2.28B+32.0% | |
| Asia Pacific | $445.5M-3.6% | $462.1M+5.7% | $437M+2.6% | $425.9M+1.6% | |
| EMEA | $596.9M+0.4% | $594.3M+9.0% | $545M+32.9% | $410.1M+1.0% | |
| Cost of Goods Sold by Geography | |||||
| Americas | $1.13B+15.4% | $983.7M+1.6% | $967.8M+5.7% | $915.6M— | |
| Asia Pacific | $437.3M+16.5% | $375.5M+3.6% | $362.5M-4.4% | $379.2M— | |
| EMEA | $683.4M+16.0% | $588.9M+8.7% | $541.8M-1.6% | $550.4M— | |
| Research And Development Expense Excluding Acquired In Process Cost by Geography | |||||
| Americas | $73.4M+1,997% | $3.5M+2.9% | $3.4M+21.4% | $2.8M— | |
| Asia Pacific | $14.1M+6.0% | $13.3M-14.7% | $15.6M-4.3% | $16.3M— | |
| EMEA | $9.8M+8.9% | $9M+30.4% | $6.9M+3.0% | $6.7M— | |
| Depreciation And Amortization by Geography | |||||
| Americas | $163.4M+8.6% | $150.4M+11.8% | $134.5M+3.2% | $130.3M-8.9% | |
| Asia Pacific | $61.2M+0.2% | $61.1M-1.9% | $62.3M-1.9% | $63.5M-4.8% | |
| Corporate Items | $137.2M+7.9% | $127.1M+0.7% | $126.2M-10.7% | $141.4M+11.3% | |
| EMEA | $66.2M+0.5% | $65.9M-1.9% | $67.2M+4.3% | $64.4M-9.8% | |
| Goodwill Foreign Currency Translation Gain Loss by Geography | |||||
| Asia Pacific | $7.3M+151% | -$14.4M-162% | -$5.5M+71.6% | -$19.4M-37.6% | |
| EMEA | $1.7M+525% | -$400K— | —— | -$27.5M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Zimmer Biomet Holdings break its business down?
- Zimmer Biomet Holdings (ZBH) reports revenue by product across 4 parts — Hips, Knees, SET and Technology And Data Bone Cement And Surgical. Each is extracted from the segment footnotes and tracked over time.
- Where does Zimmer Biomet Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Zimmer Biomet Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
